HealthSouth Corporation (HLS) Given Average Rating of “Hold” by Analysts
Shares of HealthSouth Corporation (NYSE:HLS) have been assigned an average rating of “Hold” from the ten analysts that are currently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company. The average 12-month target price among brokers that have covered the stock in the last year is $49.83.
Several research firms recently commented on HLS. Mizuho increased their target price on shares of HealthSouth Corporation from $44.00 to $47.00 and gave the company a “neutral” rating in a report on Monday, July 10th. BidaskClub lowered shares of HealthSouth Corporation from a “hold” rating to a “sell” rating in a report on Thursday, July 13th. Zacks Investment Research lowered shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a report on Monday, July 3rd. ValuEngine lowered shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Finally, Stephens began coverage on shares of HealthSouth Corporation in a report on Thursday, August 31st. They set an “overweight” rating and a $53.00 target price on the stock.
COPYRIGHT VIOLATION WARNING: “HealthSouth Corporation (HLS) Given Average Rating of “Hold” by Analysts” was posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2017/09/17/healthsouth-corporation-hls-given-average-rating-of-hold-by-analysts.html.
Shares of HealthSouth Corporation (NYSE HLS) opened at 44.94 on Friday. The company has a 50 day moving average of $44.19 and a 200 day moving average of $44.89. The company has a market cap of $4.44 billion, a PE ratio of 15.82 and a beta of 0.59. HealthSouth Corporation has a 52 week low of $36.97 and a 52 week high of $49.71.
HealthSouth Corporation (NYSE:HLS) last posted its quarterly earnings data on Monday, July 31st. The company reported $0.71 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.68 by $0.03. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. The firm had revenue of $981.30 million for the quarter, compared to analysts’ expectations of $976.46 million. During the same quarter last year, the company posted $0.69 EPS. The business’s quarterly revenue was up 6.6% on a year-over-year basis. On average, analysts expect that HealthSouth Corporation will post $2.71 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Monday, October 2nd will be issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date is Friday, September 29th. This is a positive change from HealthSouth Corporation’s previous quarterly dividend of $0.24. HealthSouth Corporation’s dividend payout ratio (DPR) is 35.29%.
In other HealthSouth Corporation news, CEO Mark J. Tarr sold 22,625 shares of the firm’s stock in a transaction on Monday, August 7th. The shares were sold at an average price of $43.00, for a total value of $972,875.00. Following the sale, the chief executive officer now owns 283,134 shares of the company’s stock, valued at approximately $12,174,762. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.60% of the stock is owned by company insiders.
Institutional investors have recently made changes to their positions in the business. Neuburgh Advisers LLC grew its holdings in HealthSouth Corporation by 40.1% in the 1st quarter. Neuburgh Advisers LLC now owns 3,072 shares of the company’s stock worth $132,000 after acquiring an additional 880 shares during the last quarter. First Mercantile Trust Co. grew its holdings in HealthSouth Corporation by 18.8% in the 2nd quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock worth $132,000 after acquiring an additional 430 shares during the last quarter. Acrospire Investment Management LLC grew its holdings in HealthSouth Corporation by 64.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 2,800 shares of the company’s stock worth $136,000 after acquiring an additional 1,100 shares during the last quarter. Advisor Group Inc. grew its holdings in HealthSouth Corporation by 33.8% in the 2nd quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock worth $149,000 after acquiring an additional 781 shares during the last quarter. Finally, Petrus Trust Company LTA bought a new stake in HealthSouth Corporation in the 2nd quarter worth $210,000. 93.10% of the stock is currently owned by institutional investors and hedge funds.
About HealthSouth Corporation
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.